IMA Clinical Research, a division of the IMA Group that provides clinical evaluation and research services, has partnered with AiCure to deploy the patient engagement company's Patient Connect tool to patients in a new effort to observe health management beyond the traditional study setting.
The 30-day program will have participants using the smartphone app to confirm adherent dosing behavior and...
Sanofi is merging its real-world data platform with New York startup Aetion’s similar evidence platform to augment its treatment development and deployment efforts, the companies announced today. Sanofi’s DARWIN platform will provide a substantial body of de-identified patient data, which the Aetion Evidence Platform will analyze those information for insights on drug effectiveness, safety and...
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding.
Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
When it comes to clinical trials, oftentimes the majority of a patient’s experience happens “off stage” in their home or community. For example, medication adherence, or nonadherence, has been a major pitfall in medicine. Studies have found that roughly one in five new prescriptions are never filled, and of those filled up to 50% are taken incorrectly.
Startups have taken notice and the digital...
A forthcoming 28-patient study in the American Heart Association's journal Stroke shows that AiCure's artificial intelligence platform led to a 50 percent improvement in adherence to oral anticoagulants.
In the study, a cohort of 28 ischemic stroke survivors was followed for 12 weeks. Fifteen were assigned to the intervention group that used AiCure's software to monitor their adherence daily, and...
Seattle-based venture capital firm Biomatics Capital, which focuses on companies innovating around healthcare and technology, has closed its initiatory fund of $200 million. This exceeds the firm’s target of $150 million and spans a range of investors including individuals, family offices and institutions.
Biomatics is particularly interested in genomics and digital health, and will use this fund...
As the connected medication adherence space matures, companies that have led the space for the past few years are fine-tuning their technology platforms, business models, and approaches to efficacy.
At the Partners Connected Health Symposium in Boston today, representatives from Abiogenix, AdhereTech, AiCure, and Medisafe shared updates on their shared mission to combat the $290 billion...
There are many approaches to using digital technology to promote medication adherence, from tiny sensors embedded in pills to Bluetooth-connected pill boxes, to simple reminder apps. There’s something of a trade-off between hardware offerings, which provide real validation and accountability but can be expensive to deploy and scale, and software offerings, which are very easy to scale, but have a...
New York City-based AiCure is launching a clinical trial to validate its smartphone camera-based approach to medication adherence. The company will work with the Cincinnati Addiction Research Center (CinARC) at the University of Cincinnati on a 12-month, 130-patient trial. (Correction: The original version of this article described the system as "video-based", but the company says that is...
